Employees: 1,256
Size SWS Hemodialysis Care (688410.SS) is a China Health Care company (Medical Specialties) with a market value of $706M, the 2885th largest of 4,790 China companies the cockpit tracks. Shares closed at CN¥10.45 on 18 Nov 2026.
Performance Over six months the shares fell 11.2%, against -15.1% for the median peer and -20.0% for the China market (cap-weighted) — 10th highest of 21 in its peer set.
Growth Revenue grew 30.8% over the last twelve months (peer median +14.8%); the operating margin is 18.7% (peer median 13.7%).
Valuation It trades at 23.5× forward earnings against a peer median of 24.4× (9th cheapest of 17).
Price implies For today's price to make sense, revenue must grow about 16% a year for seven years (Req g). Recent delivered growth is +26%, so the hurdle is -10 pp: the price already allows for a slowdown.
Capital Return on invested capital runs 18.7 points above its cost of capital (10.4% WACC).
Next results Next results expected around 29 Apr 2027 (exchange calendar; dates can move).
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|
| Revenue | CN¥959M | CN¥802M | CN¥564M | CN¥686M | CN¥379M |
| Revenue growth | — | +42% | -18% | +81% | — |
| Gross profit | CN¥533M | CN¥392M | CN¥246M | CN¥334M | CN¥156M |
| EBITDA | n/a | CN¥159M | CN¥54.0M | CN¥178M | CN¥55.2M |
| Net income | CN¥200M | CN¥146M | CN¥70.9M | CN¥194M | CN¥59.2M |
| Free cash flow | CN¥55.2M | CN¥170M | CN¥81.3M | -CN¥36.4M | CN¥234M |
| Capital expenditure | CN¥275M | CN¥156M | CN¥83.2M | CN¥113M | CN¥12.9M |
| Total debt | CN¥47.8M | CN¥64.7M | CN¥45.0M | CN¥20.4M | CN¥40.6M |
The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.
Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.
| Measure | 688410.SS | Peer median | Rank in peer set |
|---|---|---|---|
| 1-month return | +13.8% | -8.9% | 2nd highest of 21 |
| 6-month return | -11.2% | -15.1% | 10th highest of 21 |
| Distance from 52-week high | -20.8% | -38.3% | 5th highest of 21 |
| Revenue growth (TTM) | +30.8% | +14.8% | 8th highest of 21 |
| Operating margin | 18.7% | 13.7% | 5th highest of 21 |
| Forward P/E | 23.5× | 24.4× | 9th cheapest of 17 |
| Growth the price implies (Req g, 7 yrs) | 16.2% | 8.4% | 7th most demanding of 17 |
| Growth delivered (Del g) | +25.9% | +12.9% | 3rd highest of 17 |
| Hurdle (Req g minus delivered) | -9.8 pp | -9.8 pp | 9th least demanding of 17 |
| ROIC minus cost of capital | +18.7 pp | +2.5 pp | 4th highest of 21 |
| Company | Market | Market cap | 6M return | Revenue growth | Op. margin | Forward P/E | Req g | Delivered g |
|---|---|---|---|---|---|---|---|---|
| SWS Hemodialysis Care 688410.SS | China | $706M | -11% | +31% | 19% | 23.5× | 16.2% | +25.9% |
| Japan Lifeline 7575.T | Japan | $703M | +34% | +6% | 19% | 14.5× | -9.5% | +2.9% |
| Doctorglasses Chain 300622.SZ | China | $710M | -22% | +6% | 14% | 22.8× | -3.4% | +15.7% |
| Shanghai INT Medical Instruments 1501.HK | Hong Kong | $700M | -25% | +35% | 21% | 15.9× | -3.3% | +23.5% |
| Anhui Hongyu Wuzhou Medical Manufacturer 301234.SZ | China | $697M | +148% | -14% | 3% | n/a | 31.8% | -0.6% |
| Shanghai Sanyou Medical 688085.SS | China | $692M | -23% | +15% | 4% | 50.0× | 29.0% | +6.8% |
| Shenzhen Lifotronic Technology 688389.SS | China | $692M | -14% | +14% | 13% | 29.9× | 11.6% | +13.3% |
| Caina Technology 301122.SZ | China | $721M | +36% | +61% | 0% | 55.4× | n/a | n/a |
| Livsmed 491000.KS | South Korea | $687M | -47% | +89% | -77% | n/a | n/a | n/a |
| Delcath Systems DCTH | United States | $685M | +75% | +38% | 5% | 358.9× | 33.4% | +120.2% |
| Shenzhen Sunnypol Optoelectornics 002876.SZ | China | $680M | -9% | +29% | 5% | 39.0× | 10.1% | +14.2% |
| Shanghai Aladdin Biochemical Technology 688179.SS | China | $736M | -37% | +39% | 24% | 27.4× | 17.1% | +24.2% |
| BMC Medical 301367.SZ | China | $737M | -17% | +37% | 17% | 18.7× | -1.5% | +15.6% |
| Beijing Aerospace Changfeng 600855.SS | China | $738M | -44% | -10% | -19% | n/a | n/a | n/a |
| InMode INMD | United States | $741M | -8% | +2% | 18% | 9.8× | -10.8% | +12.4% |
| Shanghai Runda Medical Technology 603108.SS | China | $744M | -36% | -12% | -2% | 20.5× | 20.3% | -0.2% |
| Jiang Xi Sanxin Medtec 300453.SZ | China | $744M | -3% | +12% | 18% | 16.2× | -1.9% | +11.8% |
| Allmed Medical Products 002950.SZ | China | $747M | -32% | +14% | 8% | n/a | n/a | n/a |
| Shanghai Kinetic Medical 300326.SZ | China | $662M | -10% | -28% | 17% | 26.0× | 6.6% | -1.9% |
| Synektik SNT.WA | Poland | $662M | +10% | +32% | 24% | 13.8× | 0.2% | +47.5% |
| Sino Medical Sciences Technology 688108.SS | China | $753M | -41% | +22% | 19% | 60.0× | 27.9% | +9.9% |